Jean-Marc Sabatier

Author PubWeight™ 43.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 2007 1.85
2 Diversity of folds in animal toxins acting on ion channels. Biochem J 2004 1.43
3 Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells. J Biol Chem 2003 1.22
4 Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism. J Biol Chem 2003 1.17
5 Animal toxins acting on voltage-gated potassium channels. Curr Pharm Des 2008 1.16
6 Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor. J Biol Chem 2004 1.15
7 K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. Biochem J 2005 1.11
8 Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. Antivir Ther 2006 1.10
9 Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor. Biochim Biophys Acta 2006 1.10
10 Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane. J Biol Chem 2005 1.06
11 Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels. Mol Pharmacol 2004 1.02
12 Protein-protein recognition control by modulating electrostatic interactions. J Proteome Res 2010 1.00
13 Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells. J Biol Chem 2008 0.99
14 The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels. Biochem J 2004 0.98
15 Cobatoxin 1 from Centruroides noxius scorpion venom: chemical synthesis, three-dimensional structure in solution, pharmacology and docking on K+ channels. Biochem J 2004 0.97
16 Differential effects of maurocalcine on Ca2+ release events and depolarization-induced Ca2+ release in rat skeletal muscle. J Physiol 2005 0.97
17 Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins. J Biol Chem 2004 0.97
18 The interaction between the I-II loop and the III-IV loop of Cav2.1 contributes to voltage-dependent inactivation in a beta -dependent manner. J Biol Chem 2002 0.94
19 Contribution of the functional dyad of animal toxins acting on voltage-gated Kv1-type channels. J Pept Sci 2005 0.92
20 Toxin determinants required for interaction with voltage-gated K+ channels. Toxicon 2004 0.91
21 Blockade of NMDA receptors enhances spontaneous sharp waves in rat hippocampal slices. Neurosci Lett 2005 0.90
22 Substance P receptor blockade decreases stretch-induced lung cytokines and lung injury in rats. J Physiol 2010 0.89
23 Synthesis and characterization of Pi4, a scorpion toxin from Pandinus imperator that acts on K+ channels. Eur J Biochem 2003 0.88
24 Two conserved arginine residues from the SK3 potassium channel outer vestibule control selectivity of recognition by scorpion toxins. J Biol Chem 2013 0.88
25 Endogenous animal toxin-like human β-defensin 2 inhibits own K(+) channels through interaction with channel extracellular pore region. Cell Mol Life Sci 2014 0.86
26 Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain. Mol Pharmacol 2005 0.86
27 A maurotoxin with constrained standard disulfide bridging: innovative strategy of chemical synthesis, pharmacology, and docking on K+ channels. J Biol Chem 2003 0.85
28 Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy. Ann Neurol 2006 0.84
29 The impact of the fourth disulfide bridge in scorpion toxins of the alpha-KTx6 subfamily. Proteins 2005 0.83
30 Evolution of maurotoxin conformation and blocking efficacy towards Shaker B channels during the course of folding and oxidation in vitro. Biochem J 2002 0.82
31 Block of maurotoxin and charybdotoxin on human intermediate-conductance calcium-activated potassium channels (hIKCa1). Toxicon 2004 0.81
32 Small efficient cell-penetrating peptides derived from scorpion toxin maurocalcine. J Biol Chem 2012 0.81
33 Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes. Antiviral Res 2002 0.79
34 Molecular modeling and docking simulations of scorpion toxins and related analogs on human SKCa2 and SKCa3 channels. Peptides 2005 0.79
35 Increasing the molecular contacts between maurotoxin and Kv1.2 channel augments ligand affinity. Proteins 2005 0.78
36 Protein content analysis and antimicrobial activity of the crude venom of Montivipera bornmuelleri; a viper from Lebanon. Infect Disord Drug Targets 2014 0.78
37 Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins. Protein Sci 2007 0.78
38 Modelling of the III-IV loop, a domain involved in calcium channel Ca(v)2.1 inactivation, highlights a structural homology with the gamma subunit of G proteins. Eur J Neurosci 2002 0.78
39 Cell penetration properties of a highly efficient mini maurocalcine Peptide. Pharmaceuticals (Basel) 2013 0.78
40 Animal venoms: from deadly arsenals (toxins) to therapeutic drug candidates. Inflamm Allergy Drug Targets 2011 0.77
41 The deciphered genome of Mesobuthus martensii uncovers the resistance mysteries of scorpion to its own venom and toxins at the ion channel level. Toxins (Basel) 2013 0.77
42 Analysis of the interacting surface of maurotoxin with the voltage-gated Shaker B K(+) channel. J Pept Sci 2011 0.77
43 CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity. Behav Brain Res 2005 0.77
44 Solution structure of Pi4, a short four-disulfide-bridged scorpion toxin specific of potassium channels. Protein Sci 2003 0.76
45 SKCa Channels Blockage Increases the Expression of Adenosine A2A Receptor in Jurkat Human T Cells. Biores Open Access 2013 0.75
46 Synthesis, 3-D structure, and pharmacology of a reticulated chimeric peptide derived from maurotoxin and Tsk scorpion toxins. Biochem Biophys Res Commun 2002 0.75
47 First chemical synthesis of a scorpion alpha-toxin affecting sodium channels: the Aah I toxin of Androctonus australis hector. J Pept Sci 2004 0.75
48 Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections. Infect Disord Drug Targets 2015 0.75
49 Drug targets in viral infections. Infect Disord Drug Targets 2009 0.75
50 Chemical synthesis and characterization of J46 peptide, an atypical class IIa bacteriocin from Lactococcus lactis subsp. cremoris J46 Strain. J Antibiot (Tokyo) 2008 0.75